DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,026 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,467,603 | +9.7% | 9,946 | +6.1% | 0.66% | +2.3% |
| Q2 2023 | $2,248,800 | +26.3% | 9,370 | +32.6% | 0.64% | +15.8% |
| Q1 2023 | $1,780,915 | +36.8% | 7,066 | +44.0% | 0.56% | +51.5% |
| Q4 2022 | $1,302,151 | +18.3% | 4,906 | +15.1% | 0.37% | +23.6% |
| Q3 2022 | $1,101,000 | +1.9% | 4,264 | 0.0% | 0.30% | -1.3% |
| Q2 2022 | $1,081,000 | -14.9% | 4,264 | -1.5% | 0.30% | +44.0% |
| Q1 2022 | $1,270,000 | -2.7% | 4,328 | +9.2% | 0.21% | +33.1% |
| Q4 2021 | $1,305,000 | -11.0% | 3,965 | -17.7% | 0.16% | -32.0% |
| Q3 2021 | $1,466,000 | +13.5% | 4,816 | 0.0% | 0.23% | +30.5% |
| Q2 2021 | $1,292,000 | +26.3% | 4,816 | +6.0% | 0.18% | +39.4% |
| Q1 2021 | $1,023,000 | +7.8% | 4,543 | +6.4% | 0.13% | -42.5% |
| Q4 2020 | $949,000 | -14.0% | 4,271 | -16.6% | 0.22% | +317.0% |
| Q3 2020 | $1,103,000 | -43.5% | 5,122 | -53.6% | 0.05% | -93.6% |
| Q2 2020 | $1,951,000 | +151.4% | 11,032 | +96.6% | 0.83% | +23.1% |
| Q1 2020 | $776,000 | -5.8% | 5,610 | +4.5% | 0.67% | +31.4% |
| Q4 2019 | $824,000 | – | 5,366 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |